Teladoc Share Price (NYSE: TDOC)

$7.73

▲

-0.16

(-2.03%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Teladoc Stock chart to analyse performance

Teladoc stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.67
Today's High:$7.88
$7.73
0.78%
Downside
Day's Volatility :2.66%
Upside
1.9%
52 Weeks Low:$6.35
52 Weeks High:$15.21
$7.73
17.85%
Downside
52 Weeks Volatility :58.25%
Upside
49.18%

Teladoc Stock Returns

Period	Teladoc Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	12.45%	3.6%	0.0%
6 Months	-18.08%	-7.7%	0.0%
1 Year	4.67%	-12.6%	0.0%
3 Years	-74.92%	9.5%	-4.7%

Teladoc Inc Key Stats

Check Teladoc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.89
Open	$7.89
Today's High	$7.88
Today's Low	$7.67
Market Capitalization	$1.4B
Today's Volume	$3.5M
52 Week High	$15.21
52 Week Low	$6.35
Revenue TTM	$2.5B
EBITDA	$18.9M
Earnings Per Share (EPS)	$-1.15
Profit Margin	-8.16%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-14.18%

Stock Returns calculator for Teladoc Stock including INR - Dollar returns

The Teladoc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Teladoc investment value today

Current value as on today

₹1,10,027

Returns

₹10,027

(+10.03%)

Returns from Teladoc Stock

₹4,743 (+4.74%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Teladoc Stock

-47%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Teladoc Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Teladoc Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.90%
BlackRock Inc
8.47%
Point72 Asset Management, L.P.
4.44%
Renaissance Technologies Corp
3.70%
Dimensional Fund Advisors, Inc.
3.15%
State Street Corp
2.84%

Analyst Recommendation on Teladoc Stock

Rating

Trend

Hold

31%Buy

68%Hold

0%Sell

Based on 35 Wall street analysts offering stock ratings for Teladoc(by analysts ranked 0 to 5 stars)

Teladoc Share Price Target

What analysts predicted

Upside of 18.05%

Target:

$9.13

Current:

$7.73

Teladoc share price target is $9.13, a slight Upside of 18.05% compared to current price of $7.73 as per analysts' prediction.

Teladoc Stock Insights

Price Movement
In the last 6 months, TDOC stock has moved down by -19.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 629.36M → 631.9M (in $), with an average increase of 0.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -93.01M → -32.66M (in $), with an average increase of 184.8% per quarter
TDOC vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 77.0%
TDOC vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 183.7%
Price to Sales
ForTDOC every $1 of sales, investors are willing to pay $0.5, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Teladoc Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$553.3M	↑ 32.4%
Net Income	$-98.9M	↑ 1.83%
Net Profit Margin	-17.87%	↑ 5.36%

	FY20	Y/Y Change
Revenue	$1.1B	↑ 97.71%
Net Income	$-485.1M	↑ 390.71%
Net Profit Margin	-44.35%	↓ 26.48%

	FY21	Y/Y Change
Revenue	$2.0B	↑ 85.81%
Net Income	$-428.8M	↓ 11.61%
Net Profit Margin	-21.09%	↑ 23.26%

	FY22	Y/Y Change
Revenue	$2.4B	↑ 18.41%
Net Income	$-13.7B	↑ 3085.58%
Net Profit Margin	-567.53%	↓ 546.44%

	FY23	Y/Y Change
Revenue	$2.6B	↑ 8.13%
Net Income	$-220.4M	↓ 98.39%
Net Profit Margin	-8.47%	↑ 559.06%

	FY24	Y/Y Change
Revenue	$2.6B	↓ 1.26%
Net Income	$-1.0B	↑ 354.35%
Net Profit Margin	-38.97%	↓ 30.5%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$646.1M	↓ 2.18%
Net Income	$-81.9M	↑ 183.45%
Net Profit Margin	-12.67%	↓ 8.3%

	Q2 FY24	Q/Q Change
Revenue	$642.4M	↓ 0.57%
Net Income	$-837.7M	↑ 922.93%
Net Profit Margin	-130.39%	↓ 117.72%

	Q3 FY24	Q/Q Change
Revenue	$640.5M	↓ 0.3%
Net Income	$-33.3M	↓ 96.03%
Net Profit Margin	-5.2%	↑ 125.19%

	Q4 FY24	Q/Q Change
Revenue	$640.5M	↑ 0.0%
Net Income	$-48.4M	↑ 45.48%
Net Profit Margin	-7.56%	↓ 2.36%

	Q1 FY25	Q/Q Change
Revenue	$629.4M	↓ 1.74%
Net Income	$-93.0M	↑ 92.14%
Net Profit Margin	-14.78%	↓ 7.22%

	Q2 FY25	Q/Q Change
Revenue	$631.9M	↑ 0.4%
Net Income	$-32.7M	↓ 64.89%
Net Profit Margin	-5.17%	↑ 9.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$368.8M	↑ 27.55%

	FY20	Y/Y Change
Profit	$703.1M	↑ 90.63%

	FY21	Y/Y Change
Profit	$1.4B	↑ 96.61%

	FY22	Y/Y Change
Profit	$1.7B	↑ 20.28%

	FY23	Y/Y Change
Profit	$1.8B	↑ 10.8%

	FY24	Y/Y Change
Profit	$1.8B	↓ 1.31%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$353.7M	↓ 24.28%

	Q2 FY24	Q/Q Change
Profit	$357.8M	↑ 1.16%

	Q3 FY24	Q/Q Change
Profit	$460.8M	↑ 28.77%

	Q4 FY24	Q/Q Change
Profit	$451.6M	↓ 2.0%

	Q1 FY25	Q/Q Change
Profit	$432.5M	↓ 4.21%

	Q2 FY25	Q/Q Change
Profit	$441.4M	↑ 2.04%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$29.9M	↓ 714.59%
Investing Cash Flow	$25.0M	↓ 109.71%
Financing Cash Flow	$35.1M	↓ 94.56%

	FY20	Y/Y Change
Operating Cash Flow	$-53.5M	↓ 279.15%
Investing Cash Flow	$-591.0M	↓ 2462.67%
Financing Cash Flow	$859.1M	↑ 2348.1%

	FY21	Y/Y Change
Operating Cash Flow	$194.0M	↓ 462.52%
Investing Cash Flow	$-73.0M	↓ 87.65%
Financing Cash Flow	$40.9M	↓ 95.23%

	FY22	Y/Y Change
Operating Cash Flow	$189.3M	↓ 2.42%
Investing Cash Flow	$-167.7M	↑ 129.84%
Financing Cash Flow	$6.5M	↓ 84.13%

	FY23	Y/Y Change
Operating Cash Flow	$350.0M	↑ 84.91%
Investing Cash Flow	$-156.3M	↓ 6.79%
Financing Cash Flow	$10.9M	↑ 67.06%

	FY24	Y/Y Change
Operating Cash Flow	$293.7M	↓ 16.1%
Investing Cash Flow	$-124.1M	↓ 20.66%
Financing Cash Flow	$8.3M	↓ 23.42%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$8.9M	↓ 93.14%
Investing Cash Flow	$-35.5M	↓ 2.72%
Financing Cash Flow	$1.8M	↓ 198.65%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$88.7M	↑ 894.2%
Investing Cash Flow	$-27.7M	↓ 21.86%
Financing Cash Flow	$3.8M	↑ 117.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$110.2M	↑ 24.23%
Investing Cash Flow	$-31.1M	↑ 12.25%
Financing Cash Flow	$698.0K	↓ 81.66%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$85.9M	↓ 22.03%
Investing Cash Flow	$-29.6M	↓ 4.83%
Financing Cash Flow	$2.1M	↑ 194.84%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$15.9M	↓ 81.47%
Investing Cash Flow	$-123.3M	↑ 315.83%
Financing Cash Flow	$769.0K	↓ 62.63%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$91.4M	↑ 474.36%
Investing Cash Flow	$-59.7M	↓ 51.57%
Financing Cash Flow	$-549.9M	↓ 71612.74%

Teladoc Technicals Summary

Sell

Neutral

Buy

Teladoc is currently in a neutral trading position according to technical analysis indicators.

Teladoc Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Teladoc Inc	11.31%	-18.08%	4.67%	-74.92%	-96.55%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Teladoc Inc	NA	NA	-1.01	-1.2	-0.14	-0.04	NA	8.05
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Teladoc Inc	Hold	$1.4B	-96.55%	NA	-8.16%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Teladoc Inc

Teladoc Health Inc. founded by G. Byron Brooks and Michael Gorton is a multinational company for telemedicine and virtual healthcare in America. The company was incorporated in 2002 in Dallas, Texas, USA. Teladoc Health Inc. is headquartered in Purchase, New York, USA, and operates in more than 130 countries worldwide. The company has over 4,400 employees serving across the world. Teladoc Health primarily caters to telehealth services and devices, AI and analytics, medical opinions, and licensable platform services. It is the first and largest telemedicine company in the USA to have served 40 million members in 2021 and traded on the New York Stock Exchange as TDOC under the Russel 1000 component. Teledoc Health Inc. has acquired some of the major companies in the past few years such as BetterHelp in 2015, followed by Best Doctors and Advance Medical in 2017 and 2018, respectively. However, the company eventually dropped the lawsuit voluntarily after Texas passed a new bill allowing remote medical treatment without a physical meeting in 2017. In the financial year 2020, Teladoc Health Inc. generated annual revenue of $1.093 billion. Currently Teladoc Inc has a market cap of $1.22 Billion. It has a P.E ratio of -1.21. The shares of Teladoc Inc are trading at $7.73. .

Organization	Teladoc
Employees	4620
CEO	Mr. Charles Divita III, CPA
Industry	Health Services

Key Management of Teladoc Inc

Name	Title
Mr. Charles Divita III, CPA	CEO & Director
Ms. Mala Murthy	Chief Financial Officer
Mr. Adam Christian Vandervoort J.D.	Chief Legal Officer & Secretary
Mr. Carlos Nueno	President of International
Ms. Kelly M. Bliss	President of U.S. Group Health
Dr. George Byron Brooks BS EE, M.D.	Co-Founder
Mr. Joseph Ronald Catapano Cpa	Senior VP & Chief Accounting Officer
Mr. Nikolaos Nanis	Chief Technology Officer
Michael Minchak	Vice President of Investor Relations
Ms. Laura Whipple	Chief Communications & Brand Officer

Important FAQs about investing in TDOC Stock from India :

What is Teladoc share price today?

Teladoc share price today is $7.73 as on August 30, 2025 at 1:29 am IST at the close of the market. Teladoc share today touched a day high of $7.88 and a low of $7.67.

What is the 52 week high and 52 week low for Teladoc share?

Teladoc share touched a 52 week high of $15.21 and a 52 week low of $6.35. Teladoc stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.73, lower by 49.18% versus the 52 week high.

How to invest in Teladoc Stock (TDOC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Teladoc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Teladoc Shares that will get you 0.1940 shares as per Teladoc share price of $7.73 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Teladoc Stock (TDOC) from India?

Indian investors can start investing in Teladoc (TDOC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Teladoc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Teladoc share’s latest price of $7.73 as on August 30, 2025 at 1:29 am IST, you will get 1.2937 shares of Teladoc. Learn more about fractional shares .

What are the returns that Teladoc has given to Indian investors in the last 5 years?

Teladoc stock has given -96.55% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?